Health

Celltrion's Yuflyma (adalimumab-aaty) Receives FDA Interchangeability Designation for All Approved Dosage Forms and Strengths

DailyTrendDailyTrend
May 26, 2025 - 22:00
 0  0
Celltrion's Yuflyma (adalimumab-aaty) Receives FDA Interchangeability Designation for All Approved Dosage Forms and Strengths
INCHEON, South Korea, May 23, 2025 /PRNewswire/ -- Celltrion, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted an expanded interchangeable designation for Yuflyma (adalimumab-aaty), now including prefilled syringe...
Read More

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0
DailyTrend
DailyTrend

Related Posts

Congo Has Astronomical Rates of Sexual Violence. Now Vi...

DailyTrend Aug 22, 2025  0  0

A $45 Treatment Can Save a Starving Child. US Aid Cuts Have Frozen the Supply

A $45 Treatment Can Save a Starving Child. US Aid Cuts ...

DailyTrend Aug 16, 2025  0  0

Are Marathons and Extreme Running Linked to Colon Cancer?

Are Marathons and Extreme Running Linked to Colon Cancer?

DailyTrend Aug 20, 2025  0  0

B. Braun Medical Issues Voluntary Nationwide Recall of Lactated Ringer’s Injection USP 1000 mL and 0.9% Sodium Chloride Injection USP 1000 mL Due to the Presence of Particulate Matter

B. Braun Medical Issues Voluntary Nationwide Recall of ...

DailyTrend Aug 20, 2025  0  0

A New Way to Reduce Children’s Deaths: Cash

A New Way to Reduce Children’s Deaths: Cash

DailyTrend Aug 18, 2025  0  0

Wildfire Fighters, Unmasked in Toxic Smoke, Are Getting Sick and Dying

Wildfire Fighters, Unmasked in Toxic Smoke, Are Getting...

DailyTrend Aug 17, 2025  0  0